Fate investors have opportunity to lead fate therapeutics, inc. securities fraud lawsuit

Los angeles , feb. 9, 2023 /prnewswire/ -- glancy prongay & murray llp ("gpm") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against fate therapeutics, inc. ("fate" or the "company") (nasdaq: fate ). class period: april 2, 2020 – january 5, 2023 lead plaintiff deadline: march 22, 2023 if you wish to serve as lead plaintiff of the fate lawsuit, you can submit your contact information at www.glancylaw.com/cases/fate-therapeutics-inc/.
FATE Ratings Summary
FATE Quant Ranking